Literature DB >> 33199452

Canadian best practice recommendations for the management of amyotrophic lateral sclerosis.

Christen Shoesmith1, Agessandro Abrahao2, Tim Benstead2, Marvin Chum2, Nicolas Dupre2, Aaron Izenberg2, Wendy Johnston2, Sanjay Kalra2, Desmond Leddin2, Colleen O'Connell2, Kerri Schellenberg2, Anu Tandon2, Lorne Zinman2.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 33199452      PMCID： PMC7683000          DOI： 10.1503/cmaj.191721

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  57 in total

1.  Riluzole and other prognostic factors in ALS: a population-based registry study in Italy.

Authors:  Jessica Mandrioli; Sara Angela Malerba; Ettore Beghi; Nicola Fini; Antonio Fasano; Elisabetta Zucchi; Silvia De Pasqua; Carlo Guidi; Emilio Terlizzi; Elisabetta Sette; Alessandro Ravasio; Mario Casmiro; Fabrizio Salvi; Rocco Liguori; Lucia Zinno; Yasmin Handouk; Romana Rizzi; Annamaria Borghi; Rita Rinaldi; Doriana Medici; Mario Santangelo; Enrico Granieri; Vittoria Mussuto; Marina Aiello; Salvatore Ferro; Marco Vinceti
Journal:  J Neurol       Date:  2018-02-05       Impact factor: 4.849

2.  Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial.

Authors: 
Journal:  Lancet Neurol       Date:  2017-05-15       Impact factor: 44.182

3.  Multidisciplinary ALS care improves quality of life in patients with ALS.

Authors:  J P Van den Berg; S Kalmijn; E Lindeman; J H Veldink; M de Visser; M M Van der Graaff; J H J Wokke; L H Van den Berg
Journal:  Neurology       Date:  2005-10-25       Impact factor: 9.910

4.  "I hate being a burden": The patient perspective on carer burden in amyotrophic lateral sclerosis.

Authors:  Geraldine Foley; Virpi Timonen; Orla Hardiman
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2016-02-09       Impact factor: 4.092

5.  A multidisciplinary clinic approach improves survival in ALS: a comparative study of ALS in Ireland and Northern Ireland.

Authors:  James Rooney; Susan Byrne; Mark Heverin; Katy Tobin; Alison Dick; Colette Donaghy; Orla Hardiman
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-12-30       Impact factor: 10.154

6.  Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine: a randomized trial.

Authors:  B R Brooks; R A Thisted; S H Appel; W G Bradley; R K Olney; J E Berg; L E Pope; R A Smith
Journal:  Neurology       Date:  2004-10-26       Impact factor: 9.910

7.  A randomized controlled trial of resistance and endurance exercise in amyotrophic lateral sclerosis.

Authors:  Lora L Clawson; Merit Cudkowicz; Lisa Krivickas; Benjamin R Brooks; Mohammed Sanjak; Peggy Allred; Nazem Atassi; Amy Swartz; Gabrielle Steinhorn; Alpa Uchil; Kristen M Riley; Hong Yu; David A Schoenfeld; Nicholas J Maragakis
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2017-11-30       Impact factor: 4.092

8.  Family caregivers' accounts of caring for a family member with motor neurone disease in Norway: a qualitative study.

Authors:  Sverre Vigeland Lerum; Kari Nyheim Solbrække; Jan C Frich
Journal:  BMC Palliat Care       Date:  2016-02-24       Impact factor: 3.234

9.  Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study.

Authors:  Ton Fang; Ahmad Al Khleifat; Jacques-Henri Meurgey; Ashley Jones; P Nigel Leigh; Gilbert Bensimon; Ammar Al-Chalabi
Journal:  Lancet Neurol       Date:  2018-03-07       Impact factor: 44.182

10.  Evidence of an environmental effect on survival in ALS.

Authors:  Noa Keren; Kirsten M Scott; Miho Tsuda; Jessica Barnwell; Jonathan A Knibb; Cathy M Ellis; P Nigel Leigh; Christopher E Shaw; Ammar Al-Chalabi
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2014-05-27       Impact factor: 4.092
View more
  5 in total

Review 1.  Neuromuscular Complications of SARS-CoV-2 and Other Viral Infections.

Authors:  Sarah Jacob; Ronak Kapadia; Tyler Soule; Honglin Luo; Kerri L Schellenberg; Renée N Douville; Gerald Pfeffer
Journal:  Front Neurol       Date:  2022-06-24       Impact factor: 4.086

2.  The importance of offering early genetic testing in everyone with amyotrophic lateral sclerosis.

Authors:  Kristiana Salmon; Matthew C Kiernan; Seung H Kim; Peter M Andersen; Adriano Chio; Leonard H van den Berg; Philip Van Damme; Ammar Al-Chalabi; Patricia Lillo; Jinsy A Andrews; Angela Genge
Journal:  Brain       Date:  2022-05-24       Impact factor: 15.255

3.  Covid-19 threat and coping: application of protection motivation theory to the pandemic experiences of people affected by amyotrophic lateral sclerosis.

Authors:  Shelagh K Genuis; Westerly Luth; Tania Bubela; Wendy S Johnston
Journal:  BMC Neurol       Date:  2022-04-12       Impact factor: 2.474

4.  Comparison of Slow and Forced Vital Capacity on Ability to Evaluate Respiratory Function in Bulbar-Involved Amyotrophic Lateral Sclerosis.

Authors:  Xin Huang; Chenfang Du; Qiong Yang; Dongsheng Fan
Journal:  Front Neurol       Date:  2022-06-28       Impact factor: 4.086

5.  Correlation of weight and body composition with disease progression rate in patients with amyotrophic lateral sclerosis.

Authors:  Jin-Yue Li; Xiao-Han Sun; Zheng-Yi Cai; Dong-Chao Shen; Xun-Zhe Yang; Ming-Sheng Liu; Li-Ying Cui
Journal:  Sci Rep       Date:  2022-08-02       Impact factor: 4.996
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.